Key facts
- It has raised $1.1M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include BioTools Innovator, New Zealand Growth Capital Partners, Booster Innovation Fund, Exponential Founders Fund, Flying Kiwi Angels — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Advemto
- ·The full record, as it builds
Funding rounds
No funding rounds for Advemto are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Advemto
Developer of spectroscopy systems designed to make ultrafast dynamics visible in new materials and nature. The company creates and distributes ultrafast photoluminescence and transient absorption systems to research institutes and offers academic research to commercial and industrial applications in chemical, biological, pharmaceutical, optical, and electronics development and manufacturing, enabling researchers and industry users to get information on the dynamics of a wide range of materials for every research facility, regardless of the level of expertise.
- Sector
- Information Technology
- HQ
- Wellington, New Zealand
- Founded
- 2022
- Employees
- 8
- Website
- advemto.com/
- Ownership
- Privately Held (backing)
Advemto doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Advemto shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Advemto in its N-PORT filings yet. We sweep new filings monthly.